Description

Gujarat Kidney and Super Speciality Limited added to BSE IPO index effective January 1, 2026, and Dachepalli Publishers Limited added to BSE SME IPO index effective December 31, 2025.

Summary

BSE announces the addition of two newly listed companies to their respective indices. Gujarat Kidney and Super Speciality Limited (544666) will be added to the BSE IPO index effective January 1, 2026, following its listing on December 30, 2025. Dachepalli Publishers Limited (544667) will be added to the BSE SME IPO index effective December 31, 2025, following its listing on the SME platform on December 30, 2025.

Key Points

  • Gujarat Kidney and Super Speciality Limited (Exchange ticker: 544666) listed on BSE on December 30, 2025
  • Gujarat Kidney to be added to BSE IPO index at market open on January 1, 2026
  • Dachepalli Publishers Limited (Exchange ticker: 544667) listed on BSE SME platform on December 30, 2025
  • Dachepalli Publishers to be added to BSE SME IPO index at market open on December 31, 2025
  • Changes included in end-of-day corporate action file (*.SDE)
  • References prior notices: 20251229-15 and 20251229-31

Regulatory Changes

No regulatory changes. This is a routine index maintenance action following standard procedures for adding newly listed companies to relevant indices.

Compliance Requirements

No specific compliance requirements for market participants. Index composition changes are automatically reflected in corporate action files.

Important Dates

  • December 30, 2025: Listing date for both Gujarat Kidney and Super Speciality Limited and Dachepalli Publishers Limited
  • December 31, 2025: Dachepalli Publishers Limited added to BSE SME IPO index (at market open)
  • January 1, 2026: Gujarat Kidney and Super Speciality Limited added to BSE IPO index (at market open)

Impact Assessment

Minimal market impact. These are standard index additions for newly listed IPO companies to their respective benchmark indices (BSE IPO and BSE SME IPO). Index tracking funds and passive investment strategies following these indices will need to incorporate these stocks. The additions reflect normal market operations and do not affect trading of existing securities.

Impact Justification

Routine index additions for newly listed companies with no broader market impact